Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 10 Mar 2023

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

in Vaccines and Molecular Therapeutics

Abera Surendran
Monire Jamalkhah
Joanna Poutou
Rayanna Birtch
Christine Lawson
Jaahnavi Dave
Mathieu J. F. Crupi
Justin Mayer
Victoria Taylor
Julia Petryk

Frontiers in Immunology

doi 10.3389/fimmu.2023.1099459

5,682 views
8 citations

Review

Published on 10 Mar 2023

Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine

in Vaccines and Molecular Therapeutics

Edgar Alonso Melgoza-González
Lorena Bustamante-Córdova
Jesús Hernández

Frontiers in Immunology

doi 10.3389/fimmu.2023.1080238

7,868 views
12 citations

Study Protocol

Published on 10 Mar 2023

An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial

in Vaccines and Molecular Therapeutics

Shirin Kalimuddin
Yvonne F. Z. Chan
October M. Sessions
Kuan Rong Chan
Eugenia Z. Ong
Jenny G. Low
Antonio Bertoletti
Eng Eong Ooi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1135979

4,572 views
4 citations

Original Research

Published on 09 Mar 2023

Immunization with Tp0954, an adhesin of Treponema pallidum, provides protective efficacy in the rabbit model of experimental syphilis

in Vaccines and Molecular Therapeutics

Yuxing He
Dejun Chen
Yue Fu
Xinzhuo Huo
Feijun Zhao
Ling Yao
Xiuping Zhou
Pengfei Qi
Haoquan Yin
Longgu Cao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1130593

3,744 views
8 citations

Original Research

Published on 09 Mar 2023

Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh

in Vaccines and Molecular Therapeutics

Md. Imam Hossain
Protim Sarker
Rubhana Raqib
Md Ziaur Rahman
Rezaul Hasan
Chloe K. Svezia
Mahbubur Rahman
Nuhu Amin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1128330

3,895 views
1 citation

Brief Research Report

Published on 09 Mar 2023

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

in Vaccines and Molecular Therapeutics

Brandon Carter
Pinghan Huang
Ge Liu
Yuejin Liang
Paulo J. C. Lin
Bi-Hung Peng
Lindsay G. A. McKay
Alexander Dimitrakakis
Jason Hsu
Vivian Tat

Frontiers in Immunology

doi 10.3389/fimmu.2023.1135815

16,058 views
8 citations

Review

Published on 09 Mar 2023

Oral route lipopolysaccharide as a potential dementia preventive agent inducing neuroprotective microglia

in Vaccines and Molecular Therapeutics

Haruka Mizobuchi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1110583

5,569 views
7 citations

Original Research

Published on 07 Mar 2023

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection

in Vaccines and Molecular Therapeutics

Hakjun Hyun
A-Yeung Jang
Heedo Park
Jung Yeon Heo
Yu Bin Seo
Eliel Nham
Jin Gu Yoon
Hye Seong
Ji Yun Noh
Hee Jin Cheong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131229

3,519 views
11 citations

Systematic Review

Published on 07 Mar 2023

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

in Vaccines and Molecular Therapeutics

Patrick M. McCarthy
Franklin A. Valdera
Todd R. Smolinsky
Alexandra M. Adams
Anne E. O’Shea
Katryna K. Thomas
Spencer Van Decar
Elizabeth L. Carpenter
Ankur Tiwari
John W. Myers

Frontiers in Immunology

doi 10.3389/fimmu.2023.1090533

4,658 views
11 citations

Correction

Published on 07 Mar 2023

Corrigendum: SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from the University Hospital in Krakow, Poland

in Vaccines and Molecular Therapeutics

Izabella Owsianka
Agnieszka Pac
Estera Jachowicz
Karolina Gutkowska
Wiktor Szczuciński
Barbara Maziarz
Elżbieta Sochacka-Tatara
Piotr Heczko
Wojciech Sydor
Barbara Żółtowska

Frontiers in Immunology

doi 10.3389/fimmu.2023.1155871

1,195 views

Brief Research Report

Published on 06 Mar 2023

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study

in Vaccines and Molecular Therapeutics

Sabrina Manni
Caroline Ruetsch
Roxane Fabre
Michel Ticchioni
Daisy Graça
Christian Pradier
Barbara Seitz-Polski
Laurene Lotte
Vesna Brglez
Matteo Vassallo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1136723

2,382 views
2 citations

Original Research

Published on 06 Mar 2023

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents

in Vaccines and Molecular Therapeutics

Daniel Leung
Carolyn A. Cohen
Xiaofeng Mu
Jaime S. Rosa Duque
Samuel M. S. Cheng
Xiwei Wang
Manni Wang
Wenyue Zhang
Yanmei Zhang
Issan Y. S. Tam

Frontiers in Immunology

doi 10.3389/fimmu.2023.1106837

4,081 views
10 citations

Systematic Review

Published on 03 Mar 2023

A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults

in Vaccines and Molecular Therapeutics

Kun Xu
Zihan Wang
Maorong Qin
Yangyu Gao
Na Luo
Wanting Xie
Yihan Zou
Jie Wang
Xingming Ma

Frontiers in Immunology

doi 10.3389/fimmu.2023.1113156

20,199 views
51 citations

Original Research

Published on 03 Mar 2023

Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study

in Vaccines and Molecular Therapeutics

Youhua Yuan
Junhong Xu
Bing Ma
Guohua Chen
Zhibin Wang
Shanmei Wang
Nan Jing
Jiangfeng Zhang
Baoya Wang
Wenjuan Yan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1107866

2,863 views
12 citations

Clinical Trial

Published on 02 Mar 2023

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

in Vaccines and Molecular Therapeutics

Yi Wang
Jianhua Li
Wenhui Zhang
Shourong Liu
Liangbin Miao
Zhaoyi Li
Ai Fu
Jianfeng Bao
Lili Huang
Liping Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152695

2,890 views
10 citations

Original Research

Published on 02 Mar 2023

Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections

in Vaccines and Molecular Therapeutics

Jinyoung Yang
Gunho Won
Jin Yang Baek
Young Ho Lee
Haein Kim
Kyungmin Huh
Sun Young Cho
Cheol-In Kang
Doo Ryeon Chung
Kyong Ran Peck

Frontiers in Immunology

doi 10.3389/fimmu.2023.1139980

2,832 views
10 citations